These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 1301998)

  • 1. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distance constraints and stereospecific alignment requirements characteristic of p53 DNA-binding consensus sequence homologies.
    Cook JL; Ré RN; Giardina JF; Fontenot FE; Cheng DY; Alam J
    Oncogene; 1995 Aug; 11(4):723-33. PubMed ID: 7651736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro.
    Chène P
    Biochem Biophys Res Commun; 1999 Sep; 263(1):1-5. PubMed ID: 10486243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2.
    Scherer SJ; Welter C; Zang KD; Dooley S
    Biochem Biophys Res Commun; 1996 Apr; 221(3):722-8. PubMed ID: 8630028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R; Roth JA; Maxwell SA
    Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective binding of different p53 response elements by p53 containing complexes.
    Martinez JD; Craven MT; Pennington ME
    Oncogene; 1998 Jan; 16(4):453-8. PubMed ID: 9484834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo.
    Koga H; Deppert W
    Oncogene; 2000 Aug; 19(36):4178-83. PubMed ID: 10962580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the DNA-binding affinity, sequence specificity and context dependence of the glucocorticoid receptor zinc finger region.
    La Baer J; Yamamoto KR
    J Mol Biol; 1994 Jun; 239(5):664-88. PubMed ID: 8014988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments.
    Palecek E; Brázdová M; Cernocká H; Vlk D; Brázda V; Vojtesek B
    Oncogene; 1999 Jun; 18(24):3617-25. PubMed ID: 10380883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D; Srinivasan A; Lozano G; Robbins PD
    Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative binding of tetrameric p53 to DNA.
    Weinberg RL; Veprintsev DB; Fersht AR
    J Mol Biol; 2004 Aug; 341(5):1145-59. PubMed ID: 15321712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
    Yang AL; Festing MF
    Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.